{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Renal+Ischemia&page=3", "query": { "condition": "Renal Ischemia", "page": 3 }, "page_size": 10 }, "pagination": { "page": 3, "page_size": 10, "total_count": 93, "total_pages": 10, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Renal+Ischemia&page=4&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Renal+Ischemia&page=2&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-03T01:51:32.505Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02585713", "title": "Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous Thromboembolism", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Cerebral Vein Thrombosis", "Deep Vein Thrombosis", "Gonadal Thrombosis", "Hepatic Thrombosis", "Malignant Neoplasm", "Mesenteric Thrombosis", "Metastatic Malignant Neoplasm", "Portal Vein Thrombosis", "Pulmonary Embolism", "Renal Vein Thrombosis", "Splenic Thrombosis", "Venous Thromboembolism" ], "interventions": [ { "name": "Apixaban", "type": "DRUG" }, { "name": "Dalteparin", "type": "DRUG" }, { "name": "Questionnaire Administration", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Academic and Community Cancer Research United", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 300, "start_date": "2015-11-20", "completion_date": "2019-12-24", "has_results": true, "last_update_posted_date": "2020-08-04", "last_synced_at": "2026-10-03T01:51:32.505Z", "location_count": 18, "location_summary": "Scottsdale, Arizona • Jacksonville, Florida • Evanston, Illinois + 15 more", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Evanston", "state": "Illinois" }, { "city": "Peoria", "state": "Illinois" }, { "city": "Iowa City", "state": "Iowa" } ], "official_url": "https://clinicaltrials.gov/study/NCT02585713" }, { "nct_id": "NCT00863707", "title": "A Study of the Safety and Tolerance of Regadenoson in Subjects With Renal Impairment", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Kidney Diseases", "Coronary Artery Disease" ], "interventions": [ { "name": "Regadenoson", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Astellas Pharma Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 511, "start_date": "2009-04", "completion_date": "2009-12", "has_results": true, "last_update_posted_date": "2012-05-18", "last_synced_at": "2026-10-03T01:51:32.505Z", "location_count": 41, "location_summary": "Anniston, Alabama • Little Rock, Arkansas • Bell Gardens, California + 36 more", "locations": [ { "city": "Anniston", "state": "Alabama" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Bell Gardens", "state": "California" }, { "city": "Fullerton", "state": "California" }, { "city": "Garden Grove", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00863707" }, { "nct_id": "NCT03605810", "title": "Study to Develop a Tool to Estimate the Kidney Function in Databases Without Laboratory Data", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Renal Function" ], "interventions": [ { "name": "No Intervention", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Bayer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 5132200, "start_date": "2018-07-15", "completion_date": "2018-12-31", "has_results": false, "last_update_posted_date": "2019-12-10", "last_synced_at": "2026-10-03T01:51:32.505Z", "location_count": 1, "location_summary": "Whippany, New Jersey", "locations": [ { "city": "Whippany", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT03605810" }, { "nct_id": "NCT04141891", "title": "Advancing Understanding of Transportation Options", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Diabetic Retinopathy", "Macular Degeneration", "Glaucoma", "Retinitis Pigmentosa", "Vision Disorders", "Acute Coronary Syndrome", "Implantable Defibrillator User", "Congestive Heart Failure", "Hypertrophic Obstructive Cardiomyopathy", "Orthostatic Hypotension", "Syncope", "Presyncope", "Narcolepsy", "Dementia", "Multiple Sclerosis", "Parkinson Disease", "Brain Injuries", "Spinal Cord Injuries", "Stroke", "Vertigo", "Dizziness", "Seizures", "Substance Use", "Insulin Dependent Diabetes Mellitus", "Arthritis", "Foot--Abnormalities", "Chronic Obstructive Pulmonary Disease", "Obstructive Sleep Apnea", "End Stage Renal Disease", "Sleep Apnea", "Insomnia", "Restless Legs Syndrome" ], "interventions": [ { "name": "Driving Decision Aid", "type": "BEHAVIORAL" }, { "name": "Older Drivers Website", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of Colorado, Denver", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 529, "start_date": "2019-12-12", "completion_date": "2023-12-21", "has_results": true, "last_update_posted_date": "2025-02-21", "last_synced_at": "2026-10-03T01:51:32.505Z", "location_count": 3, "location_summary": "La Jolla, California • Aurora, Colorado • Indianapolis, Indiana", "locations": [ { "city": "La Jolla", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Indianapolis", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT04141891" }, { "nct_id": "NCT04361552", "title": "Tocilizumab for the Treatment of Cytokine Release Syndrome in Patients With COVID-19 (SARS-CoV-2 Infection)", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Cerebrovascular Accident", "Chronic Obstructive Pulmonary Disease", "Chronic Renal Failure", "Coronary Artery Disease", "Diabetes Mellitus", "Malignant Neoplasm", "SARS Coronavirus 2 Infection" ], "interventions": [ { "name": "Best Practice", "type": "OTHER" }, { "name": "Tocilizumab", "type": "BIOLOGICAL" } ], "intervention_types": [ "OTHER", "BIOLOGICAL" ], "sponsor": "Emory University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 0, "start_date": "2020-04-07", "completion_date": "2020-06-02", "has_results": false, "last_update_posted_date": "2020-06-18", "last_synced_at": "2026-10-03T01:51:32.505Z", "location_count": 1, "location_summary": "Atlanta, Georgia", "locations": [ { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT04361552" }, { "nct_id": "NCT00005485", "title": "The Jackson Heart Study of Cardiovascular Disease Among African Americans", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Cardiovascular Diseases", "Heart Diseases", "Atherosclerosis", "Coronary Disease", "Hypertension", "Cerebrovascular Disorders" ], "interventions": [], "intervention_types": [], "sponsor": "National Heart, Lung, and Blood Institute (NHLBI)", "sponsor_class": "NIH", "healthy_volunteers": true, "eligibility": { "minimum_age": "35 Years", "maximum_age": "84 Years", "sex": "ALL", "summary": "35 Years to 84 Years" }, "enrollment_count": 5306, "start_date": "2000-09-19", "completion_date": "2025-08-12", "has_results": false, "last_update_posted_date": "2025-07-09", "last_synced_at": "2026-10-03T01:51:32.505Z", "location_count": 1, "location_summary": "Jackson, Mississippi", "locations": [ { "city": "Jackson", "state": "Mississippi" } ], "official_url": "https://clinicaltrials.gov/study/NCT00005485" }, { "nct_id": "NCT00821522", "title": "The Influence of Remote Ischemic Preconditioning on Acute Kidney Injury After Cardiac Surgery", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Acute Kidney Insufficiency", "Acute Renal Insufficiency", "Acute Kidney Injury", "Ischemic Preconditioning" ], "interventions": [ { "name": "Remote Ischemic Preconditioning", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "Robert Kramer, MD", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 120, "start_date": "2008-11", "completion_date": "2010-05", "has_results": false, "last_update_posted_date": "2021-11-17", "last_synced_at": "2026-10-03T01:51:32.505Z", "location_count": 1, "location_summary": "Portland, Maine", "locations": [ { "city": "Portland", "state": "Maine" } ], "official_url": "https://clinicaltrials.gov/study/NCT00821522" }, { "nct_id": "NCT00563901", "title": "Analyzing How Genetics May Affect Response to High Blood Pressure Medications", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Hypertension", "Coronary Disease", "Cerebrovascular Accident" ], "interventions": [], "intervention_types": [], "sponsor": "University of Alabama at Birmingham", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "55 Years", "maximum_age": null, "sex": "ALL", "summary": "55 Years and older" }, "enrollment_count": 37939, "start_date": "2000-09", "completion_date": "2004-05", "has_results": false, "last_update_posted_date": "2014-03-04", "last_synced_at": "2026-10-03T01:51:32.505Z", "location_count": 2, "location_summary": "Minneapolis, Minnesota • Houston, Texas", "locations": [ { "city": "Minneapolis", "state": "Minnesota" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00563901" }, { "nct_id": "NCT05747053", "title": "Personalization of Immunosuppressive Treatment for Organ Transplant Recipients", "overall_status": "TERMINATED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Kidney Injury", "Kidney Failure", "Kidney Failure, Chronic", "Kidney Failure, Acute", "Kidney Diseases", "Kidney Transplant Rejection", "Kidney Transplant Infection", "Kidney Transplant; Complications", "Kidney Disease, Chronic", "Kidney Ischemia" ], "interventions": [ { "name": "AlloSure", "type": "DIAGNOSTIC_TEST" }, { "name": "PAXGene", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DIAGNOSTIC_TEST" ], "sponsor": "George Washington University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 105, "start_date": "2020-10-01", "completion_date": "2022-12-08", "has_results": false, "last_update_posted_date": "2024-02-26", "last_synced_at": "2026-10-03T01:51:32.505Z", "location_count": 1, "location_summary": "Washington D.C., District of Columbia", "locations": [ { "city": "Washington D.C.", "state": "District of Columbia" } ], "official_url": "https://clinicaltrials.gov/study/NCT05747053" }, { "nct_id": "NCT01047735", "title": "The TRIABETES - ARMMS-T2D Study: A Randomized Trial to Compare Surgical and Medical Treatments for Type 2 Diabetes", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Type 2 Diabetes Mellitus", "Obesity" ], "interventions": [ { "name": "Roux-en-Y Gastric Bypass Surgery", "type": "PROCEDURE" }, { "name": "Laparoscopic Adjustable Gastric Banding", "type": "PROCEDURE" }, { "name": "Lifestyle Weight Loss Intervention", "type": "BEHAVIORAL" } ], "intervention_types": [ "PROCEDURE", "BEHAVIORAL" ], "sponsor": "University of Pittsburgh", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "25 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "25 Years to 55 Years" }, "enrollment_count": 69, "start_date": "2009-09-01", "completion_date": "2028-07-01", "has_results": false, "last_update_posted_date": "2026-06-11", "last_synced_at": "2026-10-03T01:51:32.505Z", "location_count": 1, "location_summary": "Pittsburgh, Pennsylvania", "locations": [ { "city": "Pittsburgh", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT01047735" } ] }